Every two weeks
Where Measurement Stops
A note on trial design, outcome measures, and how access decisions get made years before anyone talks about price.
One email every two weeks. No spam, no selling, unsubscribe whenever you like. I read every reply myself.
Read the privacy statement.
In the Netherlands, the first approved treatment for spinal muscular atrophy was reimbursed for patients under 9.5 years old. That number came from a trial protocol, not a clinical judgment. I was 30. I write about how those lines get drawn, and what it would take to draw them differently.
Around 800 words. One idea per email. Subscribe and I will send you the Access Gap Checklist, twelve questions to ask before you lock your protocol.